XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) Statement - USD ($)
Total
Common Stock
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
AOCI Attributable to Parent [Member]
Beginning balance (shares) at Dec. 31, 2020   5,949,463      
Beginning balance at Dec. 31, 2020 $ (15,540,812) $ 5,949 $ 110,107,170 $ (123,665,970) $ (1,987,961)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss 408,295     408,295  
Share-based compensation to employees 4,471   4,471    
Shares issued in connection with vesting of restricted stock (shares)        
Shares issued in connection with vesting of restricted stock 0 0    
Accretion of Series A redeemable convertible preferred stock (197,114)   (197,114)    
Dividends on Series A redeemable convertible preferred stock (277,170)   (277,170)    
Foreign currency translation 86,398       86,398
Ending balance (shares) at Mar. 31, 2021   5,949,463      
Ending balance at Mar. 31, 2021 (15,515,932) $ 5,949 109,637,357 (123,257,675) (1,901,563)
Beginning balance (shares) at Dec. 31, 2020   5,949,463      
Beginning balance at Dec. 31, 2020 (15,540,812) $ 5,949 110,107,170 (123,665,970) (1,987,961)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss 45,995        
Accretion of Series A redeemable convertible preferred stock (272,297)        
Dividends on Series A redeemable convertible preferred stock (560,096)        
Foreign currency translation 81,658        
Ending balance (shares) at Jun. 30, 2021   6,789,364      
Ending balance at Jun. 30, 2021 (13,498,614) $ 6,789 112,020,875 (123,619,975) (1,906,303)
Beginning balance (shares) at Mar. 31, 2021   5,949,463      
Beginning balance at Mar. 31, 2021 (15,515,932) $ 5,949 109,637,357 (123,257,675) (1,901,563)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (362,300)     (362,300)  
Stock Issued During Period, Shares, New Issues 2,737,770        
Stock Issued During Period, Value, New Issues   $ 812 2,736,958    
Share-based compensation to employees $ 4,697   4,697    
Shares issued in connection with vesting of restricted stock (shares)   28,151      
Shares issued in connection with vesting of restricted stock 0 $ 28 (28)    
Accretion of Series A redeemable convertible preferred stock (75,183)   (75,183)    
Dividends on Series A redeemable convertible preferred stock (282,926)   (282,926)    
Foreign currency translation (4,740)       (4,740)
Ending balance (shares) at Jun. 30, 2021   6,789,364      
Ending balance at Jun. 30, 2021 (13,498,614) $ 6,789 112,020,875 (123,619,975) (1,906,303)
Beginning balance (shares) at Dec. 31, 2021   7,082,276      
Beginning balance at Dec. 31, 2021 (12,965,983) $ 7,082 112,349,613 (123,462,638) (1,860,040)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (1,109,406)     (1,109,406)  
Share-based compensation to employees 8,184   8,184    
Accretion of Series A redeemable convertible preferred stock (14,815)   (14,815)    
Dividends on Series A redeemable convertible preferred stock (300,921)   (300,921)    
Foreign currency translation 33,510       33,510
Ending balance (shares) at Mar. 31, 2022   7,082,276      
Ending balance at Mar. 31, 2022 (14,349,431) $ 7,082 112,042,061 (124,572,044) (1,826,530)
Beginning balance (shares) at Dec. 31, 2021   7,082,276      
Beginning balance at Dec. 31, 2021 (12,965,983) $ 7,082 112,349,613 (123,462,638) (1,860,040)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,040,632)        
Accretion of Series A redeemable convertible preferred stock (50,397)        
Dividends on Series A redeemable convertible preferred stock (639,349)        
Foreign currency translation 144,371        
Ending balance (shares) at Jun. 30, 2022   7,111,801      
Ending balance at Jun. 30, 2022 (15,524,704) $ 7,112 111,687,123 (125,503,270) (1,715,669)
Beginning balance (shares) at Mar. 31, 2022   7,082,276      
Beginning balance at Mar. 31, 2022 (14,349,431) $ 7,082 112,042,061 (124,572,044) (1,826,530)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (931,226)     (931,226)  
Share-based compensation to employees 19,102   19,102    
Shares issued in connection with vesting of restricted stock (shares)   29,525      
Shares issued in connection with vesting of restricted stock 0 $ 30 (30)    
Accretion of Series A redeemable convertible preferred stock (35,582)   (35,582)    
Dividends on Series A redeemable convertible preferred stock (338,428)   (338,428)    
Foreign currency translation 110,861       110,861
Ending balance (shares) at Jun. 30, 2022   7,111,801      
Ending balance at Jun. 30, 2022 $ (15,524,704) $ 7,112 $ 111,687,123 $ (125,503,270) $ (1,715,669)